Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”
Bleeding, Thrombosis and Vascular Biology · 10.03.2026 · 5 (1)
DOI: 10.4081/btvb.2026.463 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Bleeding, Thrombosis and Vascular Biology, online erschienen am 10.03.2026. Verfasst von Sistiana Aiello und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In the early 1970s, aspirin (acetylsalicylic acid) was shown to inhibit platelet aggregation by irreversibly acetylating platelet cyclooxygenase (COX), thereby suppressing the synthesis of its pro-aggregating product thromboxane A₂ (TxA₂)...
Zitieren
APA
Aiello, S., Benigni, A., & Remuzzi, G. (2026). Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”. Bleeding, Thrombosis and Vascular Biology, 5(1). https://doi.org/10.4081/btvb.2026.463
Vancouver
Aiello S, Benigni A, Remuzzi G. Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”. Bleeding, Thrombosis and Vascular Biology. 2026;5(1). doi:10.4081/btvb.2026.463
BibTeX
@article{Aiello2026,
author = {Aiello, Sistiana and Benigni, Ariela and Remuzzi, Giuseppe},
title = {Comments on “Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial”},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
volume = {5},
number = {1},
doi = {10.4081/btvb.2026.463}
}
EUVIMED